Tower Research Capital (TRC)’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.5K | Sell |
5,094
-771
| -13% | -$3.1K | ﹤0.01% | 3668 |
|
2025
Q1 | $20.4K | Buy |
5,865
+4,210
| +254% | +$14.6K | ﹤0.01% | 2944 |
|
2024
Q4 | $10.9K | Buy |
1,655
+238
| +17% | +$1.57K | ﹤0.01% | 3768 |
|
2024
Q3 | $12.8K | Sell |
1,417
-158
| -10% | -$1.43K | ﹤0.01% | 3561 |
|
2024
Q2 | $25.3K | Buy |
1,575
+1,068
| +211% | +$17.1K | ﹤0.01% | 3614 |
|
2024
Q1 | $7.95K | Sell |
507
-983
| -66% | -$15.4K | ﹤0.01% | 4108 |
|
2023
Q4 | $20K | Buy |
+1,490
| New | +$20K | ﹤0.01% | 3646 |
|